Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rousselot

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
Haematologica|January 26, 2006
The role of the K247R substitution in the ABL tyrosine kinase domain in sensitivity to imatinibFranck Emmanuel Nicolini, Kaddour Chabane, Jean-Michel Cayuela, et al.
Leukemia Research|May 15, 2002
Potential mechanisms of resistance to cytarabine in AML patientsCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
Blood|September 1, 2012
Second attempt to discontinue imatinib in CP-CML patients with a second sustained complete molecular responseLaurence Legros, Philippe Rousselot, Stéphane Giraudier, et al.
Platelets|February 28, 2022
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpuraMathilde Chanut, Rym Jaidi, Milena Kohn, et al.
Leukemia & Lymphoma|July 6, 2014
Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroupFrançoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomasPatricia Franchi-Rezgui, Philippe Rousselot, Marc Espié, et al.
Ejhaem|July 18, 2022
Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature reviewSolo Traoré, Mehdi Roumila, Pirayeh Eftekhari, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid LeukemiaEmmanuelle Vidal-Petiot, Delphine Rea, Fidéline Serrano, et al.
British Journal of Haematology|June 13, 2002
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemiaCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
Leukemia Research|March 10, 2021
Ponatinib long-term follow-up of efficacy and safety in CP-CML patients in real world settings in France: The POST-PACE studyGabriel Etienne, Delphine Rea, Valerie Coiteux, et al.
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
Haematologica|January 26, 2006
The role of the K247R substitution in the ABL tyrosine kinase domain in sensitivity to imatinibFranck Emmanuel Nicolini, Kaddour Chabane, Jean-Michel Cayuela, et al.
Leukemia Research|May 15, 2002
Potential mechanisms of resistance to cytarabine in AML patientsCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
Blood|September 1, 2012
Second attempt to discontinue imatinib in CP-CML patients with a second sustained complete molecular responseLaurence Legros, Philippe Rousselot, Stéphane Giraudier, et al.
Platelets|February 28, 2022
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpuraMathilde Chanut, Rym Jaidi, Milena Kohn, et al.
Leukemia & Lymphoma|July 6, 2014
Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroupFrançoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomasPatricia Franchi-Rezgui, Philippe Rousselot, Marc Espié, et al.
Ejhaem|July 18, 2022
Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature reviewSolo Traoré, Mehdi Roumila, Pirayeh Eftekhari, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid LeukemiaEmmanuelle Vidal-Petiot, Delphine Rea, Fidéline Serrano, et al.
British Journal of Haematology|June 13, 2002
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemiaCarlos M Galmarini, Xavier Thomas, Fabien Calvo, et al.
Leukemia Research|March 10, 2021
Ponatinib long-term follow-up of efficacy and safety in CP-CML patients in real world settings in France: The POST-PACE studyGabriel Etienne, Delphine Rea, Valerie Coiteux, et al.
Pageof 20